University of Oklahoma Health Sciences Center Files for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing Fluidigm Technology
April 24, 2020
April 24, 2020
NORMAN, Oklahoma, April 24 -- The University of Oklahoma issued the following news release:
OU Medicine, the OU Health Sciences Center and the Oklahoma Medical Research Foundation collaborated to create a new test for COVID-19 using technology and reagents from Fluidigm Corporation, an innovative biotechnology tools provider. The test is intended for large-scale testing of patients across the OU Medicine healthcare system, with the capacity to test 180,000 samples over the next 90 d . . .
OU Medicine, the OU Health Sciences Center and the Oklahoma Medical Research Foundation collaborated to create a new test for COVID-19 using technology and reagents from Fluidigm Corporation, an innovative biotechnology tools provider. The test is intended for large-scale testing of patients across the OU Medicine healthcare system, with the capacity to test 180,000 samples over the next 90 d . . .